linki5


donate

In Collaboration with UCL

Image

Consilium HTA

Consilium HTA works with developers of medicines, medical devices, diagnostics, and digital solutions. Our team possesses a robust foundation and experience in clinical practice, research, and commercialisation of healthcare products in the US, UK, and Europe.

Our objective is to provide compelling and insightful analyses, guidance on relevant evidence generation for regulators and payers, and answers questions about gaps in evidence, regulatory and HTA processes, competitive positioning, intellectual property, and addressing unmet clinical need.

Services

Comprehensive health economics and HTA services to support your market access journey


hta 1

Evidence Synthesis

We assist organisations with the development and delivery of high-quality evidence synthesis to support decision-making in healthcare:

  • Systematic reviews and meta-analyses
  • Targeted and narrative reviews
  • Design of registries
  • Advice on real-world data collection and use for HTA

hta 1

Quality Assurance of Economic Models

If you developed or commissioned an economic model for submission to an HTA agency or in-house analyses, Consilium HTA can:

  • Provide technical analysis of the model (quantitative and qualitative)
  • Check plausibility of assumptions in the model
  • Provide recommendations for improvement

hta 1

HTA Evidence Generation Advice

If you are preparing to undergo an HTA evaluation, it is essential that you generate clinical evidence that can enable a decision on reimbursement. Consilium HTA can review your development programme and advise you on:

  • Evidence you have available to date vs what's required
  • Critique of completed, ongoing and planned clinical trials
  • Quality of life data collection and sources
  • Approach to economic modelling
  • Use of real-world evidence
  • Patient engagement

hta 1

Medical Devices and Diagnostics

If you are investing in or developing a medical device or a diagnostic test, Consilium HTA can help by:

  • Articulating value proposition to attract investors and maximise chances of reimbursement
  • Guiding you through regulatory requirements in the US and Europe
  • Critically reviewing available clinical evidence and providing guidance on how to address the gaps
  • Guiding you through the reimbursement requirements in the UK and Europe
  • Answering your questions

hta 1

HTA Evidence Generation Advice

If you are preparing to undergo an HTA evaluation, it is essential that you generate clinical evidence that can enable a decision on reimbursement. Consilium HTA can review your development programme and advise you on:

  • Evidence you have available to date vs what's required
  • Critique of completed, ongoing and planned clinical trials
  • Quality of life data collection and sources
  • Approach to economic modelling
  • Use of real-world evidence
  • Patient engagement

hta 1

Medical Devices and Diagnostics

If you are investing in or developing a medical device or a diagnostic test, Consilium HTA can help by:

  • Articulating value proposition to attract investors and maximise chances of reimbursement
  • Guiding you through regulatory requirements in the US and Europe
  • Critically reviewing available clinical evidence and providing guidance on how to address the gaps
  • Guiding you through the reimbursement requirements in the UK and Europe
  • Answering your questions

hta 1

HTA Evidence Generation Advice

If you are preparing to undergo an HTA evaluation, it is essential that you generate clinical evidence that can enable a decision on reimbursement. Consilium HTA can review your development programme and advise you on:

  • Evidence you have available to date vs what's required
  • Critique of completed, ongoing and planned clinical trials
  • Quality of life data collection and sources
  • Approach to economic modelling
  • Use of real-world evidence
  • Patient engagement

hta 1

Medical Devices and Diagnostics

If you are investing in or developing a medical device or a diagnostic test, Consilium HTA can help by:

  • Articulating value proposition to attract investors and maximise chances of reimbursement
  • Guiding you through regulatory requirements in the US and Europe
  • Critically reviewing available clinical evidence and providing guidance on how to address the gaps
  • Guiding you through the reimbursement requirements in the UK and Europe
  • Answering your questions

Training

We offer bespoke seminars and workshops on HTA and clinical evidence. Let us know your team's needs and we'll develop customised training for you — via Zoom or in person, from 1 hour to 1 day.

1

Understanding Market Access in the UK

  • Learn about NICE processes and methods for pharmaceutical products, devices and diagnostics, cell and gene therapies, and digital health
  • Work through examples of previous appraisals and evaluations
  • Ask questions

 


 

 

 

2

Health Technology Assessment (HTA)

  • Introduction to HTA: Pharmaceuticals
  • Introduction to HTA: Medical Devices
  • Introduction to Health Economics
  • Introduction to Clinical Trials and how to ensure you meet stakeholder requirements
  • HTA in Europe


 



 

3

Evidence Interpretation

  • Research findings presented in scientific publications or in the media are subject to bias — developing acumen for understanding and critically interpreting methods and outputs of research is an important skill
  • Equipping healthcare professionals, researchers and patients with skills required to interpret scientific evidence
  • Enabling participants to conduct methodologically sound work

 

Team

Health Economics and Statistics

Prof Gianluca Baio

Dr. Nathan Green

Dr. Ioannis Rotous

 

Information/Data Science

Dr. Yevgeniya Kovalchuk

Dr. Ekaterina Cleary

 

 

Advisors

Prof Carole Longson  |  Prof Amanda Adler  |  Prof  Mark Sheehan  |  Josie Godfrey  

Sheela Upadhyaya  |  Sir Andrew Dillon

Patient & Public Engagement

Lindsay Birrell  |  Eric Low

Ready to Work With Us?

Contact our team to discuss how Consilium HTA can support your health technology assessment needs.

Search